Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.
Tuñón J, Higueras J, Tarín N, Cristóbal C, Lorenzo Ó, Blanco-Colio L, Martín-Ventura JL, Huelmos A, Alonso J, Aceña Á, Pello A, Carda R, Asensio D, Mahíllo-Fernández I, López Bescós L, Egido J, Farré J. Tuñón J, et al. Among authors: acena a. PLoS One. 2015 Jun 5;10(6):e0126741. doi: 10.1371/journal.pone.0126741. eCollection 2015. PLoS One. 2015. PMID: 26046344 Free PMC article.
Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.
Tuñón J, Cristóbal C, Tarín N, Aceña Á, González-Casaus ML, Huelmos A, Alonso J, Lorenzo Ó, González-Parra E, Mahíllo-Fernández I, Pello AM, Carda R, Farré J, Rodríguez-Artalejo F, López-Bescós L, Egido J. Tuñón J, et al. Among authors: acena a. PLoS One. 2014 Apr 18;9(4):e95402. doi: 10.1371/journal.pone.0095402. eCollection 2014. PLoS One. 2014. PMID: 24748388 Free PMC article.
[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease].
Higueras J, Martín-Ventura JL, Blanco-Colio L, Cristóbal C, Tarín N, Huelmos A, Alonso J, Pello A, Aceña Á, Carda R, Lorenzo Ó, Mahíllo-Fernández I, Asensio D, Almeida P, Rodríguez-Artalejo F, Farré J, López Bescós L, Egido J, Tuñón J. Higueras J, et al. Among authors: acena a. Clin Investig Arterioscler. 2015 Mar-Apr;27(2):57-63. doi: 10.1016/j.arteri.2014.06.003. Epub 2014 Aug 13. Clin Investig Arterioscler. 2015. PMID: 25127747 Spanish.
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.
Pello AM, Cristóbal C, Tarín N, Huelmos A, Aceña Á, Carda R, González-Casaus ML, Alonso J, Lorenzo Ó, Blanco-Colio L, Martín-Ventura JL, Franco Peláez JA, Mahíllo-Fernández I, Farré J, López-Bescós L, Egido J, Tuñón J. Pello AM, et al. Among authors: acena a. J Cardiol. 2015 Jul;66(1):22-7. doi: 10.1016/j.jjcc.2014.11.006. Epub 2014 Dec 19. J Cardiol. 2015. PMID: 25533425 Free article.
The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables.
Carda R, Aceña Á, Pello A, Cristóbal C, Tarín N, Huelmos A, Alonso J, Asensio D, Lorenzo Ó, Martín-Ventura JL, Blanco-Colio L, Farré J, López Bescós L, Egido J, Tuñón J. Carda R, et al. Among authors: acena a. Cardiology. 2015;132(1):1-8. doi: 10.1159/000381259. Epub 2015 May 14. Cardiology. 2015. PMID: 25997694 Free article.
Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.
González-Parra E, Aceña Á, Lorenzo Ó, Tarín N, González-Casaus ML, Cristóbal C, Huelmos A, Mahíllo-Fernández I, Pello AM, Carda R, Hernández-González I, Alonso J, Rodríguez-Artalejo F, López-Bescós L, Ortiz A, Egido J, Tuñón J. González-Parra E, et al. Among authors: acena a. J Bone Miner Metab. 2016 Sep;34(5):587-98. doi: 10.1007/s00774-015-0706-y. Epub 2015 Aug 23. J Bone Miner Metab. 2016. PMID: 26298279
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
Tuñón J, Fernández-Fernández B, Carda R, Pello AM, Cristóbal C, Tarín N, Aceña Á, González-Casaus ML, Huelmos A, Alonso J, Lorenzo Ó, González-Parra E, Hernández-González I, Mahíllo-Fernández I, López-Bescós L, Egido J. Tuñón J, et al. Among authors: acena a. Diabetes Metab Res Rev. 2016 Oct;32(7):685-693. doi: 10.1002/dmrr.2787. Epub 2016 Apr 25. Diabetes Metab Res Rev. 2016. PMID: 26888181
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
Martín-Reyes R, Franco-Peláez JA, Lorenzo Ó, González-Casaus ML, Pello AM, Aceña Á, Carda R, Martín-Ventura JL, Blanco-Colio L, Martín-Mariscal ML, Martínez-Milla J, Villa-Bellosta R, Piñero A, Navarro F, Egido J, Tuñón J. Martín-Reyes R, et al. Among authors: acena a. PLoS One. 2016 May 12;11(5):e0152816. doi: 10.1371/journal.pone.0152816. eCollection 2016. PLoS One. 2016. PMID: 27171378 Free PMC article.
Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.
Aceña Á, Pello AM, Carda R, Lorenzo Ó, Gonzalez-Casaus ML, Blanco-Colio LM, Martín-Ventura JL, Palfy J, Orejas M, Rábago R, Gonzalez-Parra E, Mahíllo-Fernández I, Farré J, Egido J, Tuñón J. Aceña Á, et al. J Nutr Health Aging. 2016;20(6):659-64. doi: 10.1007/s12603-015-0649-y. J Nutr Health Aging. 2016. PMID: 27273357 Free article.
Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
Tuñón J, González-Hernández I, Llanos-Jiménez L, Alonso-Martín J, Escudier-Villa JM, Tarín N, Cristóbal C, Sanz P, Pello AM, Aceña Á, Carda R, Orejas M, Tomás M, Beltrán P, Calero Rueda M, Marcos E, Serrano-Antolín JM, Gutiérrez-Landaluce C, Jiménez R, Cabezudo J, Curcio A, Peces-Barba G, González-Parra E, Muñoz-Siscart R, González-Casaus ML, Lorenzo A, Huelmos A, Goicolea J, Ibáñez B, Hernández G, Alonso-Pulpón LM, Farré J, Lorenzo Ó, Mahíllo-Fernández I, Egido J. Tuñón J, et al. Among authors: acena a. BMJ Open. 2016 Aug 5;6(8):e011287. doi: 10.1136/bmjopen-2016-011287. BMJ Open. 2016. PMID: 27496232 Free PMC article. Clinical Trial.
52 results